Please use this identifier to cite or link to this item:
http://dspace.iitrpr.ac.in:8080/xmlui/handle/123456789/2351
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Taily, I. M. | - |
dc.contributor.author | Saha, D. | - |
dc.contributor.author | Banerjee, P. | - |
dc.date.accessioned | 2021-08-05T19:33:50Z | - |
dc.date.available | 2021-08-05T19:33:50Z | - |
dc.date.issued | 2021-08-06 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/2351 | - |
dc.description.abstract | A mild and straight-forward access to pharmacologically privileged tetrahydropyrimidinones exploiting readily available Donor–Acceptor cyclopropanes (DACs) is reported. This methodology involves the Lewis acid catalyzed synthesis of uriedo-malonates from (un)symmetrical ureas and DACs followed by I2-base mediated cyclization to their corresponding tetrahydropyrimidinones. The cyclization protocol involves nucleophilic attack of the nitrogen of urea on the newly generated electrophilic acceptor end of DAC. The post functionalization offered potential biologically active molecules. | en_US |
dc.language.iso | en_US | en_US |
dc.title | [3+3] annulation via ring opening/cyclization of Donor– Acceptor cyclopropanes with (Un)symmetrical ureas: a quick access to highly functionalized tetrahydropyrimidinones | en_US |
dc.type | Article | en_US |
Appears in Collections: | Year-2019 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Full Text.pdf | 1.34 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.